Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifshitz Law PLLC Announces Investigations of Nikola Corporation (NASDAQ: NKLA), DermTech, Inc. (NASDAQ: DMTK), Adobe Inc. (NASDAQ: ADBE), and AdaptHealth Corporation (NASDAQ: AHCO)

ADBE, DMTKQ, AHCO, NKLA

NEW YORK, NY / ACCESSWIRE / October 31, 2023 /

Nikola Corporation (NASDAQ:NKLA)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company maintained deficient safety and structural controls related to its manufacturing of battery components; (ii) the foregoing deficiencies rendered Nikola's vehicles unsafe to operate and thus unusable, thereby raising the likelihood of a product recall; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are a NKLA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

DermTech, Inc. (NASDAQ:DMTK)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company failed to disclose to investors: (i) that the Company experienced challenges with collections from commercial payors; (ii) that, as a result, there was a lower average selling price for DermTech's DMT; (iii) that, as a result of the foregoing, the Company's revenue growth would be adversely impacted; and (iv) that, as a result of the foregoing, the Company's positive statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are a DMTK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

Adobe Inc. (NASDAQ:ADBE)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that Figma, a competitor of Adobe which experienced rapid revenue and market capitalization growth just prior to the Relevant Period, did not pose a serious threat to Adobe's financial success and in fact could actually be beneficial to Adobe as it might attract more users who would begin with Figma's products and graduate to Adobe's. On September 15, 2022, Adobe announced that it would acquire Figma for $20 billion-double Figma's valuation from just one year prior and at a multiple of 50 times Figma's revenues. As a result of these false and/or misleading statements and omissions, Adobe common stock traded at artificially inflated prices.

If you are an ADBE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

AdaptHealth Corporation (NASDAQ:AHCO)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that AdaptHealth and certain of its senior executives orchestrated a scheme to overcharge CMS and other insurance providers by submitting improper billing codes for diabetes equipment. Further, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Relevant Period, and that as a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices.

If you are an AHCO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.

ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: jlifshitz@lifshitzlaw.com

SOURCE: Lifshitz Law Firm, P.C.



View source version on accesswire.com:
https://www.accesswire.com/798088/lifshitz-law-pllc-announces-investigations-of-nikola-corporation-nasdaq-nkla-dermtech-inc-nasdaq-dmtk-adobe-inc-nasdaq-adbe-and-adapthealth-corporation-nasdaq-ahco



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse